<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>-related gene Rb2/p130 has been reported to be mutated in several <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> such as <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) is a common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Malaysia especially amongst the ethnic Chinese </plain></SENT>
<SENT sid="2" pm="."><plain>We screened for Rb2/p130 gene (exons 19 to 21) mutations in 53 archival NPC samples via PCR-SSCP-direct sequencing approach </plain></SENT>
<SENT sid="3" pm="."><plain>Only one sample had a base change which involved a serine to glycine substitution at codon 995 (S995G) </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that Rb2/p130 genetic alterations are infrequent in NPC and may not be essential for the pathogenesis of the disease </plain></SENT>
</text></document>